peramivir IV, zanamivir IV, and higher oral oseltamivir (Tamiflu) doses for patients hospitalized with H1N1 flu

December 2009

You'll hear about peramivir IV, zanamivir IV, and higher oral oseltamivir (Tamiflu) doses for patients hospitalized with H1N1 flu.

Peramivir is an intravenous neuraminidase inhibitor similar to Tamiflu or Relenza.

Peramivir is not approved yet...but FDA is allowing emergency use for certain patients hospitalized with 2009 H1N1 influenza.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote